Breathe Well Live Well
|
Roflumilast Gets the Go-Ahead for Patients with Asthma-COPD Overlap Syndrome
MD Magazine V. Beloglazov, from the Medical Academy named after S. I. Georgievsky in Russia, and colleagues studied the effects of roflumilast in patients with ACOS and presented the findings in a poster session at the 2015 American College of Allergy, Asthma, and … |
View full post on asthma – Google News
|
Roflumilast Reduces Airway Inflammation in Asthma Patients
Lung Disease News Inhaled corticosteroids (ICS) are recommended as the most effective treatment for asthma – ICS acts by reducing inflammation in lungs' airways and sputum production via the bronchial tubes – but their prolonged use is associated with both local and … |
View full post on asthma – Google News
|
Roflumilast reduces allergen-induced airway inflammation in patients with asthma
Healio “The studies presented here show that roflumilast has no acute bronchodilator actions in patients with mild to moderate asthma,” Philip Bardin, PhD, the director of the lung and sleep unit at Monash Health in Australia, and colleagues wrote. “This … |
View full post on asthma – Google News